Roche México is a leading healthcare company in Mexico with a 75-year history. The company focuses on creating, producing, and marketing high-quality innovative solutions to meet unmet medical needs. Their products and services contribute to disease prevention, diagnosis, and treatment, ultimately enhancing patient well-being and quality of life.
Roche México prioritizes responsibility, ethics, and commitment to sustainable development while respecting the needs of individuals, society, and the environment. The company also emphasizes the importance of feedback and encourages engagement with its audience for continuous improvement.
For pharmacovigilance purposes, Roche México actively encourages the reporting of adverse reactions and special situations related to their medical devices, providing contact information for such reports.
Additionally, for updated and evidence-based information on Roche products, individuals are directed to contact the company through specified channels.
The company operates within the biotechnology, healthcare, and pharmaceutical industries. Founded in 1896, Roche México's commitment to innovation and ethical practices positions it as a key player in the healthcare sector. While specific details of its last investment and investor information are not available, its established presence and dedication to societal well-being make it an interesting potential investment opportunity for venture capital firms seeking to align with companies prioritizing impactful healthcare solutions.
There is no investment information
No recent news or press coverage available for Roche México.
We care about your data, and we'd love to use cookies make your experience better.
